We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
+12.24%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$1.63M
Cap. Flow
-$2.91M
Cap. Flow %
-2.13%
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
2
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$5.98M
2
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
+$1.42M

Top Sells

Rank Stock Value
1
CMPX icon
Compass Therapeutics
CMPX
+$6.77M
2
ACET icon
Adicet Bio
ACET
+$3.22M
3
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$320K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIMS icon
1
Hims & Hers Health
HIMS
$6.26B
$35.1M 25.63%
3,733,381
– –
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$33.5M 24.43%
3,585,346
– –
PRDS
3
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$19.6M 14.29%
10,811,887
+773,952
+8% +$1.42M
ACRS icon
4
Aclaris Therapeutics
ACRS
$743M
$13M 9.53%
1,258,243
– –
IRON icon
5
Disc Medicine
IRON
$3.03B
$10.8M 7.9%
243,513
– –
KNTE
6
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$10.7M 7.8%
3,525,957
+1,550,956
+79% +$5.98M
SLGC
7
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$7.86M 5.74%
3,403,276
-113,196
-3% -$320K
CMPX icon
8
Compass Therapeutics
CMPX
$349M
$4.21M 3.08%
1,324,071
-2,156,652
-62% -$6.77M
QSI icon
9
Quantum-Si Incorporated
QSI
$157M
$1.65M 1.21%
924,404
– –
PHVS icon
10
Pharvaris
PHVS
$2.37B
$517K 0.38%
34,142
– –
ACET icon
11
Adicet Bio
ACET
$84.7M
– –
-34,915
Closed -$3.22M

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
VW
Veridan Wealth West Linn, Oregon $270M AUM
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM

Foresite Capital Management V's Q2 2023 Portfolio in Review

As of Q2 2023, Foresite Capital Management V held 11 positions worth $137M, up 1.2% from $135M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management V's Q2 2023 filing shows 2 increased, 2 reduced and 1 closed positions. The largest sale was Compass Therapeutics, an estimated $6.77M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management V added most to Kinnate Biopharma Inc. Common Stock in Q2 2023, an estimated $5.98M increase.
  • Foresite Capital Management V's biggest Q2 2023 reduction was Compass Therapeutics, cutting an estimated $6.77M.
  • Foresite Capital Management V fully exited Adicet Bio in Q2 2023, selling an estimated $3.22M.
  • Foresite Capital Management V's ten largest holdings make up 100% of its $137M portfolio in Q2 2023.
  • Foresite Capital Management V opened 0 new positions and closed 1 in Q2 2023.
  • Foresite Capital Management V's portfolio value rose 1.2% quarter-over-quarter to $137M.

Based on Foresite Capital Management V's 13F filing for Q2 2023, filed 11 Aug 2023.